Pamplona, Spain

Rubén Pío Osés

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rubén Pío Osés: Innovator in Lung Cancer Diagnosis

Introduction

Rubén Pío Osés is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in the area of lung cancer. His innovative approach has the potential to improve the accuracy of lung cancer diagnosis and prognosis.

Latest Patents

Rubén Pío Osés holds a patent for a method of diagnosing and/or prognosing lung cancer. The invention involves determining the level of a C4 activation fragment in a test sample and comparing it with a control sample. If the level of the C4 activation fragment is higher than that in the reference control, it indicates that the subject may suffer from lung cancer or have a poor prognosis. This method also aids in assessing the risk of developing lung cancer and determining the efficacy of medical regimens based on the C4 activation fragment. His invention is characterized by high sensitivity and specificity, making it a valuable tool in lung cancer diagnostics. He has 1 patent to his name.

Career Highlights

Throughout his career, Rubén Pío Osés has worked with various organizations, including Proyecto de Biomedicina Cima, S.L. and Fundación para la Investigación Médica Aplicada. His work in these institutions has allowed him to focus on innovative research and development in the biomedical field.

Collaborations

Rubén has collaborated with notable colleagues such as Daniel Ajona Martínez-Polo and Leticia Corrales Pecino. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Rubén Pío Osés is a distinguished inventor whose work in lung cancer diagnostics showcases the importance of innovation in medicine. His patented method offers a promising approach to improving patient outcomes in lung cancer diagnosis and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…